Claritev Corporation introduced Transparency-Based Pricing, an AI-enabled solution that converts complex government transparency data into actionable reimbursement intelligence for payers and TPAs. This innovation helps healthcare organizations manage costs by providing clear, market-informed reimbursement reference points tailored to individual claims and policies. It enhances existing reimbursement strategies by making vast public pricing data practical and explainable without requiring clients to build their own data infrastructure. Claritev plans to expand this methodology across multiple cost-containment applications, supporting more informed healthcare reimbursement decisions.
Claritev's new Transparency-Based Pricing offers actionable reimbursement intelligence from complex public market data. For readers following the health sector, here is Pluang's market snapshot as of Oct 29, 2026 20:51 WIB: out of 150 priced US health stocks, 126 rose and 24 fell. Notable movers include ALNY at USD 194.78 with a -16.19% change, NUWE at USD 6.50 with +15.04%, and MESO at USD 15.34 with +14.56%.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
